Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA Share Price    (NTPH)

Here is the latest stock price and chart of Natco Pharma. For more details, see the Natco Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

Get Details: These 3 Stocks are the Dark Horses of the Stock Market

REFRESH
Live BSE Quotes Jan 15, 2021 (Close)
Price (Rs)917.05 Open (Rs) 941.30 High (Rs) 949.10 Low (Rs) 903.25
% Change-2.16 Volume 32,477 Value (Rs) 29,985,659 52-Week H/L 995.05 / 450.00
Live NSE Quotes Jan 15, 2021 (Close)
Price (Rs)916.60 Open (Rs) 941.50 High (Rs) 944.90 Low (Rs) 903.00
% Change-2.17 Volume 355,432 Value (Rs) 325,788,971 52-Week H/L 996.00 / 402.55
Change
1 Day
-2.16%
1 Month
-3.12%
3 Months
4.60%
1 Year
47.41%
5 Years (CAGR)*
11.57%
10 Years (CAGR)*
32.14%

* Compound Annual Growth Rate

Valuation
EPS (Rs)* 26.33 P/E Ratio (x) 34.83 Market Cap (Rs m) 152,367.86 P/BV (x) 4.95
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

NATCO PHARMA Share Price Today:

NATCO PHARMA last traded price was down 2.2% to Rs 917.1 on the BSE. On the NSE, NATCO PHARMA last traded price was down 2.2% to Rs 916.6. The total volume of shares traded was 0.4 m.

Overall, the broader S&P BSE HEALTHCARE Index was down by 1.2%. And the benchmark S&P BSE SENSEX was at 49,034.7 (down 1.1%).

Over the last 30 days, the NATCO PHARMA share price is down 4.0%. And over the last one year, NATCO PHARMA share price is up 45.3%.



What else is happening in the markets today? Dig in...


Today's Market

Momentum Moves: The Week Gone By(Momentum Moves)

Nifty and Sensex ended the week gaining 0.60% and 0.52% respectively. Bulls started the week roaring but since Wednesday, the momentum seemed to be tiring.

Related Views On News

NATCO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 34.5% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 34.5% YoY). Sales on the other hand came in at Rs 5 bn (down 13.4% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 21.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 21.1% YoY). Sales on the other hand came in at Rs 5 bn (down 8.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

More Views on News

Most Popular

My Top Stock Recommendation for 2021 and Beyond (Profit Hunter)

Jan 5, 2021

My new guide will show you the huge potential in future proof businesses.

'Essential' Smallcap Stock Recommendations (Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top (Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit (Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Five Wishes and a Will (The Honest Truth)

Jan 4, 2021

Ajit Dayal on the investing strategy for 2021 and beyond.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA 5-YR ANALYSIS

COMPARE NATCO PHARMA WITH

MARKET STATS